Viatris Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2026 / 05:00PM GMT
Release Date Price: MXN219.58
Christopher Schott
JPMorgan Chase & Co - Analyst

Good morning. I'm Chris Schott at JPMorgan, and it's my pleasure to be hosting this fireside discussion this morning with Viatris. We're going to have a quick presentation from CEO, Scott Smith, and they're going to open up to a Q&A session with the broader management team as well.

So with that, I'll turn it over to Scott.

Scott Smith
Viatris Inc - Chief Executive Officer, Director

Thank you, Chris, and thank you, everybody who has attended us today. Very nice for you to come. Just let me click this over. Forward-looking statement to put on here for a second. We're going to be talking about forward-looking things.

So just before we get started, I'd like to just give a little snapshot about Viatris and who we are as a company. We're not one business. We're actually three separate businesses, as a global generics company, an established brands company that owns some of the most iconic brands in the world that you can see up there, and an emerging innovative brands platform. Over the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot